Healthcare Infection Control Practices Advisory Committee (HICPAC), 63844-63845 [2010-26113]

Download as PDF 63844 Federal Register / Vol. 75, No. 200 / Monday, October 18, 2010 / Notices Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, October 13, 2010, 7 p.m. to October 14, 2010, 5 p.m., Radisson National Airport, 2020 Jefferson Davis Highway, Arlington, VA 22202 which was published in the Federal Register on September 16, 2010, 179 FR 56551. The meeting location has changed. The meeting will be held at the Hilton Crystal City at Washington Reagan National Airport, 2399 Jefferson Davis Highway in Arlington, VA 22202. The meeting is closed to the public. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. mstockstill on DSKH9S0YB1PROD with NOTICES [FR Doc. 2010–26144 Filed 10–15–10; 8:45 am] BILLING CODE 4163–18–P [FR Doc. 2010–26192 Filed 10–15–10; 8:45 am] Name of Committee: National Institute of Environmental Health Sciences Special Emphasis Panel; Toxicology Training Using Systems-Based Technology. Date: November 1, 2010. Time: 2:30 p.m. to 4:30 p.m. Agenda: To review and evaluate grant applications. Place: Nat. Inst. of Environmental Health Sciences, Building 101, Rodbell Auditorium, 111 T. W. Alexander Drive, Research Triangle Park, NC 27709. Contact Person: Leroy Worth, PhD, Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, Nat. Institute of Environmental Health Sciences, P. O. Box 12233, MD EC– 30/Room 3171, Research Triangle Park, NC 27709, (919) 541–0670, worth@niehs.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Healthcare Infection Control Practices Advisory Committee (HICPAC) Health Resources and Services Administration CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment (CHACHSPT) BILLING CODE 4140–01–P Jkt 223001 Dated: October 8, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. Centers for Disease Control and Prevention [FR Doc. 2010–26183 Filed 10–15–10; 8:45 am] 16:45 Oct 15, 2010 Dated: October 8, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. authority to sign Federal Register Notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry. DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: October 7, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. VerDate Mar<15>2010 Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the CDC announces the following meeting of the aforementioned committee: Times and Dates: 9 a.m.–5 p.m., November 4, 2010. 9 a.m.–12 p.m., November 5, 2010. Place: Washington Marriott at Metro Center, Salons C–D, 775 12th Street, NW., Washington, DC 20005 Status: This meeting is open to the public, limited only by the space available. Please register for the meeting online at https://www.cdc.gov/hicpac or by sending an e-mail to hicpac@cdc.gov. Purpose: The Committee is charged with providing advice and guidance to the Secretary, the Assistant Secretary for Health, the Director, CDC, and the Director, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), regarding the practice of healthcare infection control and strategies for surveillance, prevention, and control of healthcare-associated infections (e.g., nosocomial infections), antimicrobial resistance, and related events in settings where healthcare is provided, including hospitals, ambulatory and long-term care facilities, and home health agencies. The Committee shall advise CDC on periodic updating of guidelines and other policy statements regarding prevention of healthcare-associated infections and healthcare-related conditions. Matters To Be Discussed: The agenda will include updates on CDC’s activities for healthcare-associated infections; the draft guideline for the Prevention of Norovirus Gastroenteritis Outbreaks in Healthcare Settings; draft guideline for prevention of infections among patients in neonatal intensive care units (NICU); draft guideline for Infection Control in Healthcare Personnel; and discussion of In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), CDC/HRSA announces the following meeting of the aforementioned committee: Times and Dates: 8 a.m.–5:30 p.m., November 15, 2010. 8 a.m.–3 p.m., November 16, 2010. Place: Omni Shoreham Hotel, 2500 Calvert Street, NW., (at Connecticut Avenue) Washington, DC 20008. Telephone: (202) 234–0700. Status: Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people. Purpose: This Committee is charged with advising the Director, CDC, and the Administrator, HRSA, regarding activities related to prevention and control of HIV/ AIDS and other STDs; the support of health care services to persons living with HIV/ AIDS; and the education of health professionals and the public about HIV/AIDS and other STDs. Matters To Be Discussed: Agenda items include issues regarding: (1) HHS coordination and implementation of the National HIV/AIDS Strategy; (2) CHACHSPT Realignment Program Review Workgroup update; (3) update on strategies to educate the medical community on the need to routinely offer HIV testing to females, older persons, and other patients determined to be at low risk; and (4) updates on HIV prevention research and program implementation. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Margie Scott-Cseh, CDC, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, 1600 Clifton Road, NE., Mailstop E–07, Atlanta, Georgia 30333, Telephone (404) 639–8317. The Director, Management Analysis and Services Office, has been delegated the PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\18OCN1.SGM 18OCN1 Federal Register / Vol. 75, No. 200 / Monday, October 18, 2010 / Notices infection control in ambulatory care settings. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Michelle King, HICPAC, Division of Healthcare Quality Promotion, CDC, l600 Clifton Road, NE., Mailstop A–07, Atlanta, Georgia 30333. Telephone (404) 639–2936. E-mail: hicpac@cdc.gov. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: October 8, 2010. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–26113 Filed 10–15–10; 8:45 am] Name of Committee: National Institute of Mental Health Special Emphasis Panel; Services Conflicts. Date: November 12, 2010. Time: 11 a.m. to 12 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Aileen Schulte, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd, Room 6140, MSC 9608, Bethesda, MD 20892–9608, 301–443–1225, aschulte@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.242, Mental Health Research Grants; 93.281, Scientist Development Award, Scientist Development Award for Clinicians, and Research Scientist Award; 93.282, Mental Health National Research Service Awards for Research Training, National Institutes of Health, HHS) Dated: October 8, 2010. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2010–26161 Filed 10–15–10; 8:45 am] BILLING CODE 4140–01–P National Institutes of Health DEPARTMENT OF HEALTH AND HUMAN SERVICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. mstockstill on DSKH9S0YB1PROD with NOTICES National Institute of Mental Health; Notice of Closed Meetings Food and Drug Administration Name of Committee: National Institute of Mental Health Special Emphasis Panel; ITVA Conflicts & Eating Disorders. Date: November 10, 2010. Time: 1 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Neuroscience Center, 6001 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Francois Boller, MD, PhD, Scientific Review Officer, Division of Extramural Activities, National Institute of Mental Health, NIH, Neuroscience Center, 6001 Executive Blvd., Room 6142, MSC 9606, Bethesda, MD 20892–9606, 301–443–1513, bollerf@mail.nih.gov. VerDate Mar<15>2010 16:45 Oct 15, 2010 Jkt 223001 [Docket No. FDA–2010–N–0389] Medical Device User Fees; Public Meeting; Extension of Comment Period AGENCY: Food and Drug Administration, HHS. ACTION: Notice; extension of comment period. The Food and Drug Administration (FDA) is extending to November 1, 2010, the comment period for the notice that appeared in the Federal Register of August 13, 2010 (75 FR 49502). In the notice, FDA requested input and comments from interested stakeholders on the Agency’s medical user fee program and requested suggestions regarding the commitments FDA should propose for the next reauthorized program. The Agency is taking this action to allow interested persons additional time to submit comments. SUMMARY: Submit either electronic or written comments and information by November 1, 2010. ADDRESSES: Submit electronic comments to https:// www.regulations.gov. Submit written comments to the Division of Dockets DATES: PO 00000 Frm 00048 Fmt 4703 Sfmt 9990 63845 Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. To ensure consideration, all comments must be received by November 1, 2010. Identify comments with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: James Swink, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 1609, Silver Spring, MD 20993–0002, 301–796–6313, FAX: 301–847–8121, e-mail: James.Swink@fda.hhs.gov. SUPPLEMENTARY INFORMATION: I. Background In the Federal Register of August 13, 2010 (75 FR 49502), FDA published a notice announcing a public meeting on September 14, 2010, and the opening of a public docket to seek input and comments from interested stakeholders to discuss the Agency’s medical user fee program and requested suggestions regarding the commitments FDA should propose for the next reauthorized program. Interested persons were invited to submit comments to the public docket by October 14, 2010. At this time, the Agency is announcing its intention to post the transcript of the September 14, 2010, public meeting and is extending the comment period until November 1, 2010, to continue to receive public comments. II. Request for Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES) either electronic or written comments regarding this document. It is only necessary to send one set of comments. It is no longer necessary to send two copies of mailed comments. Identify comments with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Dated: October 14, 2010. Leslie Kux, Acting Assistant Commissioner for Policy. [FR Doc. 2010–26253 Filed 10–14–10; 4:15 pm] BILLING CODE 4160–01–P E:\FR\FM\18OCN1.SGM 18OCN1

Agencies

[Federal Register Volume 75, Number 200 (Monday, October 18, 2010)]
[Notices]
[Pages 63844-63845]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-26113]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Healthcare Infection Control Practices Advisory Committee
(HICPAC)

In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the CDC announces the following meeting
of the aforementioned committee:
Times and Dates:
9 a.m.-5 p.m., November 4, 2010.
9 a.m.-12 p.m., November 5, 2010.
Place: Washington Marriott at Metro Center, Salons C-D, 775 12th
Street, NW., Washington, DC 20005
Status: This meeting is open to the public, limited only by the
space available. Please register for the meeting online at https://www.cdc.gov/hicpac or by sending an e-mail to hicpac@cdc.gov.
Purpose: The Committee is charged with providing advice and
guidance to the Secretary, the Assistant Secretary for Health, the
Director, CDC, and the Director, National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID), regarding the practice of
healthcare infection control and strategies for surveillance,
prevention, and control of healthcare-associated infections (e.g.,
nosocomial infections), antimicrobial resistance, and related events in
settings where healthcare is provided, including hospitals, ambulatory
and long-term care facilities, and home health agencies. The Committee
shall advise CDC on periodic updating of guidelines and other policy
statements regarding prevention of healthcare-associated infections and
healthcare-related conditions.
Matters To Be Discussed: The agenda will include updates on CDC's
activities for healthcare-associated infections; the draft guideline
for the Prevention of Norovirus Gastroenteritis Outbreaks in Healthcare
Settings; draft guideline for prevention of infections among patients
in neonatal intensive care units (NICU); draft guideline for Infection
Control in Healthcare Personnel; and discussion of

[[Page 63845]]

infection control in ambulatory care settings.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Michelle King, HICPAC,
Division of Healthcare Quality Promotion, CDC, l600 Clifton Road, NE.,
Mailstop A-07, Atlanta, Georgia 30333. Telephone (404) 639-2936. E-
mail: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: October 8, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-26113 Filed 10-15-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.